| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |